Ultragenyx Pharmaceutical Inc (RARE)

70.74
NASDAQ : Health Care
Prev Close 71.96
Day Low/High 70.03 / 75.01
52 Wk Low/High 46.52 / 117.12
Avg Volume 655.50K
Exchange NASDAQ
Shares Outstanding 40.86M
Market Cap 2.94B
EPS -4.00
P/E Ratio 35.80
Div & Yield N.A. (N.A)

Latest News

Ultragenyx Reports Positive Interim Data From Phase 2 Study Of KRN23 For The Treatment Of Tumor-Induced Osteomalacia

Ultragenyx Reports Positive Interim Data From Phase 2 Study Of KRN23 For The Treatment Of Tumor-Induced Osteomalacia

Company to host conference call at 11am ET Monday, September 19 to discuss results

These 5 Stocks Are Breaking Out This Summer

These 5 Stocks Are Breaking Out This Summer

These five technical setups are showing solid upside potential right now.

16 Biopharma Companies Besides Medivation That Are Attractive Targets

16 Biopharma Companies Besides Medivation That Are Attractive Targets

Besides Sanofi, Biogen is the next most likely to complete a sizable transaction in the next 12 months, according to Credit Suisse analysts.